Ironwood Pharmaceuticals (IRWD) Competitors $0.61 -0.04 (-6.50%) As of 12:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IRWD vs. ZBIO, MYGN, VSTM, RIGL, EBS, XOMA, LXRX, VNDA, CDXS, and SGMOShould you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include Zenas Biopharma (ZBIO), Myriad Genetics (MYGN), Verastem (VSTM), Rigel Pharmaceuticals (RIGL), Emergent BioSolutions (EBS), XOMA (XOMA), Lexicon Pharmaceuticals (LXRX), Vanda Pharmaceuticals (VNDA), Codexis (CDXS), and Sangamo Therapeutics (SGMO). These companies are all part of the "biotechnology" industry. Ironwood Pharmaceuticals vs. Zenas Biopharma Myriad Genetics Verastem Rigel Pharmaceuticals Emergent BioSolutions XOMA Lexicon Pharmaceuticals Vanda Pharmaceuticals Codexis Sangamo Therapeutics Zenas Biopharma (NASDAQ:ZBIO) and Ironwood Pharmaceuticals (NASDAQ:IRWD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, community ranking, risk, institutional ownership, earnings, analyst recommendations and media sentiment. Do analysts prefer ZBIO or IRWD? Zenas Biopharma currently has a consensus target price of $36.67, suggesting a potential upside of 221.07%. Ironwood Pharmaceuticals has a consensus target price of $4.78, suggesting a potential upside of 684.15%. Given Ironwood Pharmaceuticals' higher possible upside, analysts clearly believe Ironwood Pharmaceuticals is more favorable than Zenas Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zenas Biopharma 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Ironwood Pharmaceuticals 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13 Is ZBIO or IRWD more profitable? Zenas Biopharma has a net margin of 0.00% compared to Ironwood Pharmaceuticals' net margin of -0.65%. Zenas Biopharma's return on equity of 0.00% beat Ironwood Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Zenas BiopharmaN/A N/A N/A Ironwood Pharmaceuticals -0.65%-0.96%0.74% Does the MarketBeat Community prefer ZBIO or IRWD? Ironwood Pharmaceuticals received 511 more outperform votes than Zenas Biopharma when rated by MarketBeat users. However, 100.00% of users gave Zenas Biopharma an outperform vote while only 60.73% of users gave Ironwood Pharmaceuticals an outperform vote. CompanyUnderperformOutperformZenas BiopharmaOutperform Votes4100.00% Underperform VotesNo VotesIronwood PharmaceuticalsOutperform Votes51560.73% Underperform Votes33339.27% Which has higher earnings and valuation, ZBIO or IRWD? Zenas Biopharma has higher earnings, but lower revenue than Ironwood Pharmaceuticals. Zenas Biopharma is trading at a lower price-to-earnings ratio than Ironwood Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZenas Biopharma$5M95.55-$148.51M-$3.55-3.22Ironwood Pharmaceuticals$317.68M0.31-$1.00B-$0.20-3.05 Does the media prefer ZBIO or IRWD? In the previous week, Zenas Biopharma had 32 more articles in the media than Ironwood Pharmaceuticals. MarketBeat recorded 34 mentions for Zenas Biopharma and 2 mentions for Ironwood Pharmaceuticals. Ironwood Pharmaceuticals' average media sentiment score of 1.08 beat Zenas Biopharma's score of 0.14 indicating that Ironwood Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zenas Biopharma 1 Very Positive mention(s) 0 Positive mention(s) 24 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ironwood Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryZenas Biopharma beats Ironwood Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRWD vs. The Competition Export to ExcelMetricIronwood PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.87M$6.58B$5.41B$8.53BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-20.379.2126.7719.96Price / Sales0.31257.57395.44121.37Price / CashN/A65.8538.2534.62Price / Book-0.286.576.874.60Net Income-$1.00B$144.25M$3.23B$248.27M7 Day Performance-6.01%5.13%5.32%2.28%1 Month Performance-13.46%9.67%13.56%16.43%1 Year Performance-91.00%-0.88%17.86%8.15% Ironwood Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRWDIronwood Pharmaceuticals4.5658 of 5 stars$0.61-6.5%$4.78+684.2%-89.8%$98.87M$317.68M-20.37220Positive NewsZBIOZenas BiopharmaN/A$9.74+7.6%$40.00+310.7%N/A$407.46M$5M-2.74N/ATrending NewsEarnings ReportAnalyst RevisionGap UpMYGNMyriad Genetics4.1146 of 5 stars$4.25+9.3%$16.04+277.3%-82.2%$391.75M$837.60M-3.272,600Analyst DowngradeGap DownHigh Trading VolumeVSTMVerastem3.1665 of 5 stars$7.29+1.7%$14.33+96.6%-30.8%$375.36M$10M-2.2950Insider TradeRIGLRigel Pharmaceuticals3.0062 of 5 stars$18.61-0.9%$36.40+95.6%+110.7%$332.51M$179.28M132.94160Positive NewsEBSEmergent BioSolutions4.4803 of 5 stars$5.85+3.6%$14.33+144.9%+19.7%$318.03M$1.01B-1.432,420Analyst RevisionXOMAXOMA4.1785 of 5 stars$24.79+2.5%$69.50+180.4%+6.3%$296.32M$10.22M-7.1210News CoveragePositive NewsInsider TradeAnalyst RevisionGap DownLXRXLexicon Pharmaceuticals3.235 of 5 stars$0.67-3.9%$3.67+444.1%-67.8%$243.61M$31.08M-0.90140VNDAVanda Pharmaceuticals4.4269 of 5 stars$4.03+2.0%$16.50+309.4%-15.7%$237.50M$198.77M-12.59290CDXSCodexis3.4102 of 5 stars$2.64+7.3%$8.00+203.0%-27.9%$218.71M$59.35M-3.03250Positive NewsEarnings ReportAnalyst RevisionGap UpSGMOSangamo Therapeutics1.9087 of 5 stars$0.75+7.1%$5.17+588.9%-18.8%$171.90M$57.80M-1.00480Analyst Revision Related Companies and Tools Related Companies Zenas Biopharma Alternatives Myriad Genetics Alternatives Verastem Alternatives Rigel Pharmaceuticals Alternatives Emergent BioSolutions Alternatives XOMA Alternatives Lexicon Pharmaceuticals Alternatives Vanda Pharmaceuticals Alternatives Codexis Alternatives Sangamo Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRWD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRWD Stock Free IRWD Stock Alerts